Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Amgen Inc (AMGN)
Amgen Inc (AMGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 145,809,248
  • Shares Outstanding, K 535,178
  • Annual Sales, $ 26,323 M
  • Annual Income, $ 6,552 M
  • 60-Month Beta 0.58
  • Price/Sales 5.48
  • Price/Cash Flow 11.08
  • Price/Book 18.85
Trade AMGN with:

Options Overview Details

View History
  • Implied Volatility 18.61% ( +0.53%)
  • Historical Volatility 23.12%
  • IV Percentile 11%
  • IV Rank 18.47%
  • IV High 27.77% on 10/27/23
  • IV Low 16.53% on 09/01/23
  • Put/Call Vol Ratio 0.68
  • Today's Volume 5,771
  • Volume Avg (30-Day) 7,019
  • Put/Call OI Ratio 0.94
  • Today's Open Interest 137,949
  • Open Int (30-Day) 139,845

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 21 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate 4.67
  • Number of Estimates 12
  • High Estimate 5.09
  • Low Estimate 4.35
  • Prior Year 4.09
  • Growth Rate Est. (year over year) +14.18%

Price Performance

See More
Period Period Low Period High Performance
1-Month
260.52 +4.58%
on 11/21/23
274.95 -0.91%
on 11/06/23
+11.61 (+4.45%)
since 11/01/23
3-Month
248.38 +9.69%
on 09/06/23
288.46 -5.55%
on 10/13/23
+15.74 (+6.13%)
since 09/01/23
52-Week
211.71 +28.69%
on 06/01/23
288.46 -5.55%
on 10/13/23
-13.49 (-4.72%)
since 12/01/22

Most Recent Stories

More News
1 Spectacular Dividend Stock Every Investor Should Consider

This biotech pioneer has been an exceptional growth and income stock.

AMGN : 272.45 (+1.04%)
3 Biotech Stocks Beating BioMarin Pharmaceutical (BMRN)

Breakthrough developments, the use of advanced technologies, and rising investments in R&D are some of the factors driving the growth of the biotech industry. Although BioMarin Pharmaceutical (BMRN) showcases...

AMGN : 272.45 (+1.04%)
BMRN : 92.42 (+1.47%)
JAZZ : 119.11 (+0.74%)
VRTX : 351.16 (-1.03%)
2 Top Biotech Stocks to Buy Right Now

Don't give up on these stocks too fast.

AMGN : 272.45 (+1.04%)
MRNA : 79.83 (+2.74%)
November Buy Alert: 3 Biotech Stocks Making Gains

Given the breakthrough developments and the rising need to treat chronic diseases, the biotech industry is well-positioned to generate returns. This might make buying biotech stocks like Organogenesis...

AMGN : 272.45 (+1.04%)
INVA : 13.99 (+1.01%)
ORGO : 2.73 (+7.06%)
Epidemiology and Genetics of Clonal Hematopoiesis, a Premalignant Hematopoietic Stem Cell Condition

/CNW/ -- A comprehensive new study from deCODE genetics, a subsidiary of Amgen, published today in Nature Genetics, provides insights into the epidemiology and...

AMGN : 272.45 (+1.04%)
Get Ready for Next Generation of Diabetes, Weight-Management Drugs

NetworkNewsWire Editorial Coverage : GLP-1 agonists have become incredibly popular obesity drugs, reshaping the standard of care as people increasingly turn to the new class of drugs in lieu of conventional...

LEXX : 1.5800 (+5.33%)
JNJ : 158.38 (+2.41%)
SNY : 46.72 (-0.06%)
AMGN : 272.45 (+1.04%)
NVS : 98.13 (+0.23%)
5 Dow stocks to track during the market correction

The Dow Jones Industrial Average is struggling in correction territory, but savvy investors keep an eye on resilient stocks like Microsoft, Amgen, and Walmart.

AMGN : 272.45 (+1.04%)
IBM : 160.55 (+1.26%)
MSFT : 374.51 (-1.16%)
UNH : 547.16 (-1.05%)
WMT : 154.34 (-0.87%)
SPY : 459.10 (+0.59%)
Get Ready for Next Generation of Diabetes, Weight-Management Drugs

EQNX::TICKER_START (NASDAQ:LEXX),(NYSE:JNJ),(NYSE:SNY),(NASDAQ:AMGN),(NYSE:NVS) EQNX::TICKER_END

LEXX : 1.5800 (+5.33%)
JNJ : 158.38 (+2.41%)
SNY : 46.72 (-0.06%)
AMGN : 272.45 (+1.04%)
NVS : 98.13 (+0.23%)
Investor patience tested as pharmaceutical stocks take a tumble

The healthcare sector faces a selloff as pharmaceutical giants report lackluster earnings; even Amgen's strong results failed to prevent selling in the sector

SPY : 459.10 (+0.59%)
ABBV : 143.41 (+0.72%)
AMGN : 272.45 (+1.04%)
LLY : 584.04 (-1.18%)
XLV : 131.83 (+0.40%)
JNJ : 158.38 (+2.41%)
MRK : 103.46 (+0.96%)
NVO : 100.40 (-1.41%)
PFE : 28.91 (-5.12%)
SNY : 46.72 (-0.06%)
XLU : 63.53 (+1.23%)
BMY : 50.10 (+1.46%)
Amgen: Q3 Earnings Snapshot

Amgen: Q3 Earnings Snapshot

AMGN : 272.45 (+1.04%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Amgen Inc. is the leading biotech companies world wide, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health & nephrology and neuroscience markets. It developed two most successful drugs, Epogen & Neupogen. Amgen successfully launched two...

See More

Key Turning Points

3rd Resistance Point 279.12
2nd Resistance Point 275.86
1st Resistance Point 274.15
Last Price 272.45
1st Support Level 269.18
2nd Support Level 265.92
3rd Support Level 264.21

See More

52-Week High 288.46
Last Price 272.45
Fibonacci 61.8% 259.14
Fibonacci 50% 250.08
Fibonacci 38.2% 241.03
52-Week Low 211.71

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar